These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 21284353

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Allergy-immunology. New therapies for acute attacks in hereditary angioedema].
    Leimgruber A.
    Rev Med Suisse; 2011 Jan 19; 7(278):103-5. PubMed ID: 21400938
    [Abstract] [Full Text] [Related]

  • 3. Icatibant for the treatment of hereditary angioedema.
    Cole SW, Lundquist LM.
    Ann Pharmacother; 2013 Jan 19; 47(1):49-55. PubMed ID: 23249729
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review results].
    Kawalec P, Holko P, Paszulewicz A, Obtułowicz K.
    Pneumonol Alergol Pol; 2013 Jan 19; 81(2):95-104. PubMed ID: 23420425
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
    Craig TJ, Levy RJ, Wasserman RL, Bewtra AK, Hurewitz D, Obtułowicz K, Reshef A, Ritchie B, Moldovan D, Shirov T, Grivcheva-Panovska V, Kiessling PC, Keinecke HO, Bernstein JA.
    J Allergy Clin Immunol; 2009 Oct 19; 124(4):801-8. PubMed ID: 19767078
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study.
    Zanichelli A, Bova M, Coerezza A, Petraroli A, Triggiani M, Cicardi M.
    Allergy; 2012 Aug 19; 67(8):1074-7. PubMed ID: 22686628
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
    Riedl M.
    Clin Ther; 2012 Mar 19; 34(3):623-30. PubMed ID: 22386830
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternatives.
    Maurer M, Magerl M.
    J Dtsch Dermatol Ges; 2011 Feb 19; 9(2):99-107. PubMed ID: 20946572
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hereditary angioedema: management of laryngeal attacks.
    Christiansen SC, Zuraw BL.
    Am J Rhinol Allergy; 2011 Feb 19; 25(6):379-82. PubMed ID: 22185739
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).
    Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W.
    J Allergy Clin Immunol; 2007 Jun 19; 119(6):1497-503. PubMed ID: 17418383
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.